eMedicine Specialties > Nephrology > Chronic Kidney Disease
Encephalopathy, Uremic: Treatment & Medication
Updated: Oct 29, 2009
- Overview
- Differential Diagnoses & Workup
- Treatment & Medication
- Follow-up
Treatment
Medical Care
No medications are specific to the treatment of encephalopathy.
- The presence of uremic encephalopathy in a patient with either acute kidney failure or chronic kidney failure is an indication for the initiation of dialytic therapy (ie, hemodialysis, peritoneal dialysis, continuous renal replacement therapy). After beginning dialysis, the patient generally improves clinically, although EEG findings may not improve immediately.
- In patients with end-stage renal disease (ESRD), EEG abnormalities generally improve after several months but may not completely normalize.
- Address the following factors when treating uremic encephalopathy, which are also included in the standard care of any patient with ESRD:
- Adequacy of dialysis
- Correction of anemia
- Regulation of calcium and phosphate metabolism
Consultations
- Consult a neurologist if symptoms do not improve upon initiation of dialysis therapy.
- Consult a vascular surgeon for placement of vascular access in patients with ESRD.
- Refer patients with ESRD to a dietitian familiar with renal diseases.
Diet
- To avoid malnutrition in patients with ESRD, maintain adequate protein intake (>1 g/kg/d) and initiate dialysis (despite the presence of encephalopathy).
Activity
Instruct patients with significant symptoms to continue bed rest.
More on Encephalopathy, Uremic |
| Overview: Encephalopathy, Uremic |
| Differential Diagnoses & Workup: Encephalopathy, Uremic |
Treatment & Medication: Encephalopathy, Uremic |
| Follow-up: Encephalopathy, Uremic |
| References |
| « Previous Page | Next Page » |
References
Bolton CF, Young GB. Encephalopathy of chronic renal failure. In: Neurological Complications of Renal Disease. 1990:49-74.
Brouns R, De Deyn PP. Neurological complications in renal failure: a review. Clin Neurol Neurosurg. Dec 2004;107(1):1-16. [Medline].
Arieff AI. Nervous system manifestations of renal failure. In: Schrier RW, ed. Diseases of the Kidney. Lippincott; 2007:2460-2482.
Biasioli S, D'Andrea G, Feriani M, Chiaramonte S, Fabris A, Ronco C, et al. Uremic encephalopathy: an updating. Clin Nephrol. Feb 1986;25(2):57-63. [Medline].
Biasioli S. Neurologic aspects of dialysis. In: Nissenson A, Fine R, eds. Clinical Dialysis. 2005:855-876.
Moe SM, Sprague SM. Uremic encephalopathy. Clin Nephrol. Oct 1994;42(4):251-6. [Medline].
Deguchi T, Isozaki K, Yousuke K, Terasaki T, Otagiri M. Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier. J Neurochem. Feb 2006;96(4):1051-9. [Medline].
De Deyn PP, Vanholder R, Eloot S, et al. Guanidino compounds as uremic (neuro)toxins. Semin Dial. Jul-Aug 2009;22(4):340-5. [Medline].
Liu M, Liang Y, Chigurupati S, Lathia JD, Pletnikov M, Sun Z, et al. Acute kidney injury leads to inflammation and functional changes in the brain. J Am Soc Nephrol. Jul 2008;19(7):1360-70. [Medline].
Yamamoto T, Satomura K, Okada S, et al. Risk factors for neurological complications in complete hemolytic uremic syndrome caused by Escherichia coli O157. Pediatr Int. Apr 2009;51(2):216-9. [Medline].
Further Reading
Keywords
uremic encephalopathy, encephalopathy, uremia, encephalopathies, metabolic encephalopathy, treatment encephalopathy, uremic syndrome
Treatment & Medication: Encephalopathy, Uremic